Lindbrook Capital’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.73K | Buy |
1,237
+570
| +85% | +$1.26K | ﹤0.01% | 2187 |
|
|
2024
Q4 | $3.64K | Sell |
667
-937
| -58% | -$5.11K | ﹤0.01% | 2119 |
|
|
2024
Q3 | $13.3K | Buy |
1,604
+34
| +2% | +$283 | ﹤0.01% | 1523 |
|
|
2024
Q2 | $11.2K | Buy |
1,570
+832
| +113% | +$5.96K | ﹤0.01% | 1563 |
|
|
2024
Q1 | $6.4K | Sell |
738
-58
| -7% | -$503 | ﹤0.01% | 1789 |
|
|
2023
Q4 | $5.21K | Buy |
796
+379
| +91% | +$2.48K | ﹤0.01% | 1860 |
|
|
2023
Q3 | $4.17K | Sell |
417
-428
| -51% | -$4.28K | ﹤0.01% | 1841 |
|
|
2023
Q2 | $10.5K | Sell |
845
-89
| -10% | -$1.11K | ﹤0.01% | 1436 |
|
|
2023
Q1 | $13.1K | Buy |
934
+572
| +158% | +$8.01K | ﹤0.01% | 1288 |
|
|
2022
Q4 | $5.18K | Buy |
+362
| New | +$5.18K | ﹤0.01% | 1806 |
|